A method for evaluating the level of soluble ß-amyloid(1-40/1-42) in Alzheimer's disease based on the binding of gelsolin to ß-amyloid peptides.
A method for evaluating the level of soluble ß-amyloid(1-40/1-42) in Alzheimer's disease based on the binding of gelsolin to ß-amyloid peptides. Angew Chem Int Ed Engl. 2014 Nov 17; 53(47):12832-5.